Tavaborole Solution
Product Images NDC 51862-690

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tavaborole (NDC 51862-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tavaborole 01)

FDA Label Image

Figure A And Figure B (Tavaborole 02)

FDA Label Image

Figure C (Tavaborole 03)

FDA Label Image

Figure D (Tavaborole 04)

FDA Label Image

Figure E And Figure F (Tavaborole 05)

FDA Label Image

Principal Display Panel (10 mL Bottle Label)

Principal Display Panel (10 mL Bottle Label)
NDC 51862-690-10 is a topical solution with 5% Tavaborole for external use only. It must not be used orally, vaginally or ophthalmically. The product must be stored between 20-25°C (68-77°F), with short-term excursions between 15-30°C (59-86°F) allowed. This 10mL product package has natural rubber in its packaging. It is only available with a prescription and is distributed by Mayne Pharma in Greenville, NC 27834. Code: GO/DRUGS/361.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.